Related Experiment Video
Updated: Mar 21, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Strontium ranelate increases osteoblast activity
Monica Marletti Almeida1, Edson Parra Nani1, Lucas Novaes Teixeira2
1Laboratory of Immunology and Molecular Biology, São Leopoldo Mandic Institute and Research Center, Campinas, SP, Brazil.
Strontium ranelate (SR) promotes osteoblast differentiation and bone formation in vitro. While low doses are safe, high doses of SR decrease cell proliferation and viability but enhance bone marker expression.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoporosis treatment aims to stimulate bone formation and inhibit resorption.
- Strontium ranelate (SR) is a novel osteoporosis medication with anabolic and antiresorptive properties.
Purpose of the Study:
- To investigate the in vitro effects of strontium ranelate (SR) on osteoblastic cell cultures.
- To evaluate SR's impact on cell proliferation, viability, osteoblastic marker expression, and matrix mineralization.
Main Methods:
- MC3TE-E1 osteoblastic cells were exposed to varying concentrations of SR (0.05, 0.1, 0.5mM).
- Assays included cell counting, MTT assay, Western Blotting, ELISA, Real Time PCR, epifluorescence, and Alizarin Red staining.
- Evaluated parameters: cell proliferation, viability, Type I Collagen, Osteopontin (OPN), fibronectin (FN) expression, and matrix mineralization.
Main Results:
- SR at 0.05 and 0.1mM did not affect cell proliferation or viability.
- SR at 0.5mM significantly decreased cell proliferation and viability.
- SR treatment increased Type I Collagen and OPN expression and promoted matrix mineralization in a dose-dependent manner.
- SR facilitated fibronectin expression in osteoblastic cells.
Conclusions:
- Strontium ranelate (SR) accelerates osteoblastic differentiation and enhances bone formation markers in vitro.
- SR rebalances bone turnover towards formation, particularly at higher concentrations.
- Results suggest SR's potential as an effective osteoporosis treatment by promoting osteoblast activity.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...

